CIK 0001653087
- Accelerated filer
- Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 822933343
- Phone
- +1 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,087
- in 3 filings
Net −$296,087. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-03 | Kenkare-Mitra Sara President and Head of R&D | Sale | −13,926 | $4.88 | $68K | 291,715 |
| 2024-09-03 | Romano Gary Chief Medical Officer | Sale | −8,478 | $4.88 | $41K | 179,795 |
| 2024-08-22 | SCHELLER RICHARD H Director | Sale | −44,250 | $5.16 | $228K | 35,000 |
| 2024-08-12 | Hammond Paula Director | Sale 10b5-1 | −10,500 | $5.06 | $53K | 60,209 |
| 2024-08-12 | Yaffe Kristine Director | Sale 10b5-1 | −5,000 | $5.06 | $25K | 67,709 |
| 2024-06-03 | Rosenthal Arnon Chief Executive Officer | Sale | −25,135 | $4.80 | $121K | 1,975,245 |
| 2024-06-03 | Romano Gary Chief Medical Officer | Sale | −8,040 | $4.80 | $39K | 188,273 |
| 2024-06-03 | Kenkare-Mitra Sara President and Head of R&D | Sale | −13,206 | $4.80 | $63K | 305,641 |
| 2024-06-03 | GRASSO MARC Chief Financial Officer | Sale | −6,920 | $4.80 | $33K | 138,037 |
| 2024-03-04 | Romano Gary Chief Medical Officer | Sale | −6,001 | $6.92 | $42K | 196,313 |
| 2024-03-04 | Kenkare-Mitra Sara President and Head of R&D | Sale | −10,169 | $6.92 | $70K | 318,847 |
| 2024-03-04 | GRASSO MARC Chief Financial Officer | Sale | −5,716 | $6.92 | $40K | 144,957 |
| 2024-03-04 | Rosenthal Arnon Chief Executive Officer | Sale | −18,837 | $6.92 | $130K | 2,000,380 |
| 2023-12-04 | Rosenthal Arnon Chief Executive Officer | Sale | −23,831 | $5.56 | $133K | 2,019,217 |
| 2023-12-04 | Romano Gary Chief Medical Officer | Sale | −5,035 | $5.56 | $28K | 202,314 |
| 2023-12-04 | GRASSO MARC Chief Financial Officer | Sale | −4,574 | $5.56 | $25K | 150,673 |
| 2023-12-04 | Kenkare-Mitra Sara President and Head of R&D | Sale | −12,519 | $5.56 | $70K | 329,016 |
| 2023-09-11 | Polaris Venture Management Co. VI, L.L.C. 10% owner | Sale | −500,000 | $6.00 | $3.0M | 10,853,817 |
| 2023-09-11 | MCGUIRE TERRANCE Director | Sale | −500,000 | $6.00 | $3.0M | 10,853,817 |
| 2023-09-05 | Rosenthal Arnon Chief Executive Officer | Sale | −5,647 | $5.19 | $29K | 1,645,448 |
Page 3 of 13 · 249 trades